US OptionsDetailed Quotes
TGTX250502C41500
- 3.72
- +1.27+51.84%
15min DelayTrading Apr 30 13:53 ET
3.72High3.72Low
3.72Open2.45Pre Close4 Volume29 Open Interest41.50Strike Price1.49KTurnover36.00%IV0.67%PremiumMay 2, 2025Expiry Date3.42Intrinsic Value100Multiplier2DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.9991Delta0.0025Gamma12.83Leverage Ratio-0.0050Theta0.0023Rho12.82Eff Leverage0.0001Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet